Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms
暂无分享,去创建一个
Melis N. Anahtar | E. Rosenberg | J. Lennerz | J. Branda | Maheetha Bharadwaj | S. Turbett | A. Dighe | M. Anahtar | T. Miller | T. Gogakos | M. Astudillo | S. Durbin | W. G. Garcia Beltran | Jason Thomas | Hannah Scott
[1] Dena R. Voss,et al. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays , 2020, The journal of applied laboratory medicine.
[2] H. Haslacher,et al. Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity , 2020, medRxiv.
[3] Linqi Zhang,et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection , 2020, Nature.
[4] Akihide Ryo,et al. Interpreting Diagnostic Tests for SARS-CoV-2. , 2020, JAMA.
[5] Sheng Zhang,et al. Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Y. Yazdanpanah,et al. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.
[7] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[8] Tara C Smith,et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19 , 2020, mBio.
[9] A. Hinckley,et al. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease , 2019, MMWR. Morbidity and mortality weekly report.
[10] S. Morimoto,et al. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites , 2017, Journal of Natural Medicines.
[11] W. Bower,et al. Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[12] K. Workowski,et al. Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[13] G. Pugliese,et al. Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.
[14] M. Hausmann,et al. Performance characteristics of the ARCHITECT anti-HCV assay. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[15] P. Woo,et al. Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus Pneumonia , 2005, Journal of Clinical Microbiology.
[16] Y. Leo,et al. Profiles of Antibody Responses against Severe Acute Respiratory Syndrome Coronavirus Recombinant Proteins and Their Potential Use as Diagnostic Markers , 2004, Clinical Diagnostic Laboratory Immunology.
[17] I. Hernández-Aguado,et al. False-Positive Tests for Syphilis Associated with Human Immunodeficiency Virus and Hepatitis B Virus Infection among Intravenous Drug Abusers , 1998, European Journal of Clinical Microbiology and Infectious Diseases.
[18] David C. Yeo,et al. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays , 2020, Journal of Clinical Virology.
[19] K. Workowski,et al. Sexually Transmitted Diseases Treatment Guidelines, 2015 , 2015 .